ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 254677 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 254677; 2) Community: the network communities that were significantly associated with the response to NSC 254677; 3) Molecule: the relationships between components within communities and NSC 254677; 4) MDR: the compounds that were significantly associated with the NSC 254677.

NSC Compound Enrichment Correlation
NSC 704639 Null 0.0181211508101519 -0.097262074
NSC 714598 Molybdate (2-), tetrathioxo-, diammonium, (T-4)- 0.0181211508101519 -0.30119747
NSC 717065 Null 0.0181211508101519 -0.23934747
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 0.0181211508101519 -0.25449089
NSC 722877 Null 0.0181211508101519 -0.099263966
NSC 724058 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0181211508101519 -0.3100285
NSC 735846 Null 0.0181211508101519 -0.14011267
NSC 7364 Metoprine(USAN) 0.0181211508101519 -0.19073988
NSC 744650 Null 0.0181211508101519 -0.14642233
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.0181211508101519 -0.19780717
Total:109  Current:46    [First] [Prev] [Next] [Last]